newsfilter
← Latest News
GlobeNewswire·

Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlights

- Initiated ARTEMIS, the first-ever registrational intravitreal gene therapy trial, in both treatment-experienced and treatment-naive patients with wet AMD - Presented the first human data mapping cell-level